Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 29 Jul 2026 for Viking Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleBrian Lian
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Brian Lian: trading record in brief
Brian Lian (chief executive) discloses dealings in Viking Therapeutics, Inc. to SEC (Form 4). In total, 25 filings cover trades dated from 28 September 2021 to 29 July 2026.
No open-market purchase appears, only 4 sales worth €7.2M. Besides market trades, the filings include 12 share grants and 9 option exercises. So far in 2026, the count stands at no purchases and 1 sale.
On 29 July 2026 came the latest disclosure, a share grant in Viking Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Brian Lian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
221,667 shares0Common Stock, par value $0.00001 per shareSEC:0001193125-26-324448:0
148,517 shares@ US$33.31530.12% mcap43.6% of flowCommon Stock, par value $0.00001 per shareSEC:0001193125-26-324448:1
78,400 shares0Common Stock, par value $0.00001 per shareSEC:0001193125-26-003113:0
70,084 shares0Common Stock, par value $0.00001 per shareSEC:0001193125-25-254299:0
48,333 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-25-093793:0
92,800 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-25-002487:0
166,130 shares@ US$7.7720.0% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-24-108576:0
1,000 shares@ US$7.770.1% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-24-099982:0
112,870 shares@ US$7.7713.7% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-24-098803:0
41,000 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-24-088544:0
221,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-005117:0
221,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-004233:0
45,000 shares@ US$29.9021.6% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-003068:0
49,079 shares@ US$1.231.0% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-003010:0
85,000 shares@ US$1.231.7% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-002512:0
35,000 shares@ US$1.230.7% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-002458:0
150,000 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-000931:0
45,000 shares@ US$22.4515.9% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-026356:0
35,000 shares@ US$21.4511.9% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-025277:0
125,000 shares@ US$2.154.3% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-024724:0
54,336 shares@ US$1.881.6% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-024228:0
115,852 shares@ US$1.232.3% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-022400:0
121,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-23-001340:0
36,319 shares@ US$4.881.6% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-22-001986:0
55,500 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-21-058253:0
25 of 25 declarations
